Short answer
agilon health, inc. (AGL) filed an 8-K current report with the SEC on February 25, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q4 and full-year 2025 earnings released Feb 25, 2026: covering periods ended December 31, 2025.
agilon health, inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 earnings released Feb 25, 2026: covering periods ended December 31, 2025
- Full financial results contained in Exhibit 99.1 press release; no figures disclosed in the 8-K body itself
Item 7.01 · Regulation FD Disclosure
- AGL released investor presentation (Exhibit 99.2) covering Q4 and full-year 2025 financial results
- Presentation furnished, not filed: limits legal liability but reduces formal SEC disclosure obligations
- Key figures and operational detail contained in Exhibit 99.2; review alongside Exhibit 99.1 (earnings release)
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other agilon health, inc. 8-K filings
Get the next AGL 8-K as it lands
Follow AGL for push alerts, or ask the research agent what this filing means.